8-K: AIxCrypto Sells Note Package to CABG Acquisition Corp.

AIxCrypto Holdings, Inc. has entered into a note purchase agreement to sell its interest in a package of notes and related security agreements to CABG Acquisition Corp.

Summary

• AIxCrypto Holdings, Inc. has entered into a material definitive agreement to sell its rights and interests in a 'Note Package' to CABG Acquisition Corp.
• The Note Package includes a secured demand promissory note from Marizyme, Inc. with an outstanding principal of approximately $4,771,142, plus accrued interest at 18% per annum.
• It also includes a Co-Development Note from Marizyme, Inc. for $1,750,000, with potential investment returns based on the commercial success of the DuraGraft product.
• A security agreement granting AIxCrypto a security interest in substantially all of Marizyme's assets is also part of the package.
• The total consideration includes $100,000 in cash, royalty payments of 10% on Net Revenue exceeding $20,000,000, and a 4.99% membership interest in the Buyer (CABG Acquisition Corp.).
• AIxCrypto will also have preemptive rights and customary registration rights related to its membership interest in the Buyer.
• The agreement allows for termination if closing does not occur within 90 days, provided neither party is in material breach.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral to slightly positive development, as it provides immediate cash and a stake in the acquirer, but it also involves selling off existing debt instruments and relies on future commercial success for significant upside.

Positives

• Secures $100,000 in immediate cash consideration.
• Potential for future royalty payments on Net Revenue exceeding $20,000,000.
• Acquires a 4.99% membership interest in the acquiring entity, CABG Acquisition Corp., offering potential upside.
• Includes customary preemptive and registration rights for the acquired membership interest.

Negatives

• The sale involves divesting a significant note package with a principal amount of approximately $4.77 million plus interest.
• The royalty payments are contingent on future commercial success and exceeding a $20 million Net Revenue threshold.
• The agreement can be terminated by either party if closing does not occur within 90 days.

Risks

• The commercial success of the DuraGraft product, which impacts potential returns from the Co-Development Note, is uncertain.
• The Buyer's commitment to acquire and commercialize Marizyme's assets or cause another entity to do so carries execution risk.
• The 90-day termination clause introduces a risk of the deal not closing.
• The value of the 4.99% membership interest in CABG Acquisition Corp. is subject to the future performance and valuation of that entity.

Future Outlook

The future outlook for AIxCrypto Holdings, Inc. is tied to the commercialization efforts of CABG Acquisition Corp. regarding Marizyme's assets and the potential success of the DuraGraft product, which could lead to future royalty payments. The company also gains a minority stake in the acquiring entity.

Industry Context

StockSavvy.ai notes that this transaction represents a strategic shift for AIxCrypto Holdings, Inc., moving away from direct debt and co-development interests in Marizyme towards a more passive investment in the acquiring entity and potential future royalties. This type of divestiture can be a way for companies to monetize assets that require significant future investment or carry substantial risk, while retaining some upside.

Stakeholder Impact

• Shareholders: May see a short-term boost from cash infusion and potential long-term upside from the equity stake, but also a reduction in direct asset holdings.
• Creditors: The sale of the note package may impact the company's balance sheet by reducing its debt assets.
• Employees: No direct impact mentioned in the filing.
• Customers: No direct impact mentioned in the filing.
• Suppliers: No direct impact mentioned in the filing.

Next Steps

• Closing of the transactions contemplated under the Note Purchase Agreement on a mutually agreed date.
• CABG Acquisition Corp. to acquire and commercialize, or cause another entity to acquire and commercialize, the assets of Marizyme.
• AIxCrypto Holdings, Inc. to receive its membership interest in CABG Acquisition Corp.

Key Dates

Recommendation

The filing details a strategic asset sale, providing immediate cash and a minority equity stake in the buyer, alongside potential future royalties. While this diversifies AIxCrypto's holdings and monetizes existing debt, the ultimate value is contingent on future commercial success and the performance of the acquiring entity. This warrants a 'hold' as investors await further developments on the commercialization front and the valuation of the acquired membership interest.

Keywords

Note Purchase Agreement, AIxCrypto Holdings, CABG Acquisition Corp., Marizyme, Inc., Promissory Note, Co-Development Note, Security Agreement, Asset Sale